marijuana stocks news

Charlotte’s Web Holdings, Inc. to Host Earnings Call

 

Charlotte’s Web Holdings, Inc. (CWBHF) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 24, 2020 at 8:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60610

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Anything Technologies Media Inc. (EXMT) Signs MOU to Acquire Bitcoin Super Highway Asset Management Company

Anything Technologies Media Signs MOU to Acquire Bitcoin Super Highway Asset Management…

Curaleaf Holdings, Inc. (CURLF) Opens Two New Retail Locations in Greater Philadelphia and Finalizes Rebrand of Nine Retail Locations in Pennsylvania

Curaleaf Opens Two New Retail Locations in Greater Philadelphia and Finalizes Rebrand…

$GWPH Reports Third Quarter 2015 Financial Results

GW Pharmaceuticals plc Reports Third Quarter 2015 Financial Results and Operational Progress…

GT Biopharma Inc. (GTBP) Announces Completion of First Four Patients in FDA Phase 2 Trial of Cancer Drug OXS-1550

GT Biopharma Announces Completion of First Four Patients in FDA Phase 2…